Five Flagship Ventures Portfolio Companies Named Winners of Red Herring 100 Awards for 2007

Five Flagship Ventures Portfolio Companies Named Winners of Red Herring 100 Awards for 2007

May 8, 2007

CAMBRIDGE, Mass., May 8, 2007--(BUSINESS WIRE)--Flagship Ventures announced today that five companies from its portfolio of venture investments were named winners of the Red Herring 100 for 2007. Codon Devices, Interactive Supercomputing, Mascoma, Pervasis Therapeutics, and ZoomInfo were chosen from over 800 entries in the 10th annual competition. During the past decade, the Red Herring 100 has come to be an eagerly awaited list highlighting some of the most promising companies and entrepreneurs in the high tech and life science start-up world.

"The five Flagship companies honored this year are prime examples of the principles that drive our investing philosophy: innovation, entrepreneurship, and commercialization coming together to create shareholder value," said Noubar Afeyan, CEO and Managing Partner of Flagship.

Each company represents an innovative leader in their industry:

- Codon Devices was recognized for its potential to fundamentally transform biotechnology research and development in the pharmaceutical, agriculture and renewable energy industries. (John Danner, CEO;

- Interactive Supercomputing earned the honor for creating a novel way for scientists, engineers and analysts to tap the power of supercomputers to solve some of the world's most significant challenges. (Bill Blake, CEO;

- Mascoma was named for the important role it is playing to ensure that we have climate friendly and cost competitive biofuels in the future. (Bruce Jamerson, CEO;

- Pervasis Therapeutics, Inc. was cited as a pioneer in regenerative cell-based therapies and devices, and is currently developing technologies to restore natural blood flow to critical organs. (Steve Bollinger, President;

- ZoomInfo has created the premier business information search engine, delivering quick and easy access to in-depth information on more than 35 million people and 3.8 million companies. (Jonathan Stern, CEO;

Afeyan added, "We are pleased to have been early investors in each of these leading companies, congratulate their entire teams on selection for this prestigious recognition and applaud Red Herring for taking an appropriately broad view of the many important markets in which innovation is occurring."

About Flagship Ventures

Flagship Ventures is an early-stage venture capital firm focused on creating, financing, and building innovative companies in the Life Science and Technology sectors. Headquartered in Cambridge, MA, Flagship Ventures was founded in 1999 and manages $350 million in capital. Prior to its founding, Flagship's principals were involved as founders or investors in over 100 firms including: Adolor, Anesta, Antigenics, Aspect Medical, Astral Point, BuyerZone, Celera Genomics, ChemGenics Pharmaceuticals, Color Kinetics, Chantry Networks, Cytyc, DataSage, Exact Sciences, IDEXX, PerSeptive Biosystems, and TripAdvisor. For more information, visit


Noubar Afeyan
Managing Partner & CEO
Flagship Ventures